Medical/Pharmaceuticals

Icon Group Committed to Uninterrupted Cancer Care in ASEAN

SINGAPORE, April 22, 2020 /PRNewswire/ -- Patients in Singapore and the ASEAN region can now receive care as close to home as possible through Icon Cancer Centres' remote support services which include telemedicine and home delivery for medication. This service ensures minimal disruption to the c...

2020-04-22 11:00 2217

Standigm selects CDD Vault to augment its Drug Discovery AI technology

The hosted informatics platform will facilitate the advancement of Standigm's collaborative drug discovery projects SEOUL, South Korea and SAN FRANCISCO, April 22, 2020 /PRNewswire/ -- Originally published here: https://www.collaborativedrug.com/standigm-selects-cdd-vault-augment-drug-discovery-a...

2020-04-22 08:00 1910

WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany

SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug product manufacturing plant in Leverkusen,Ge...

2020-04-22 08:00 2244

Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization

SEOUL, South Korea, April 22, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. ...

2020-04-22 07:40 2481

BodyViz Launches International Reseller Program to Assist Universities in Moving Anatomy Labs Online

BodyViz unveils strategy to deliver online virtual dissection for anatomy programs in higher education and medical institutions across the world CLIVE, Iowa, April 22, 2020 /PRNewswire/ -- BodyViz, a leader in 3D anatomy learning technology, has launched an all-new international reseller program ...

2020-04-22 00:10 1766

Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma

SYDNEY, April 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for67Cu-SARTATE™, a therapy for the clinica...

2020-04-21 21:13 1177

FibroGenesis Announces the Filing of its 200th Patent for Fibroblast Cell Therapy Platform

Building on a World Leading Intellectual Property Position with the 200th Patent Filed Today HOUSTON, April 21, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), today ...

2020-04-21 21:13 1616

Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets

STUART, Florida, April 21, 2020 /PRNewswire/ -- Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed t...

2020-04-21 21:00 2733

World's first face mask made from coffee - an eco-friendly message from AirX

HO CHI MINH CITY, Vietnam, April 21, 2020 /PRNewswire/ -- The disposal of face masks and medical waste during the COVID-19 pandemic is putting increasing pressure on the environment. According to statistics during the COVID-19 pandemic inMainland China, 116 million tons of masks were consumed eve...

2020-04-21 20:14 2709

Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity

- New, €100 million facility will more than double existing production capacity - Supports large-scale commercial manufacturing of viral and gene therapy products DARMSTADT, Germany, April 21, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced a secondCarlsbad,...

2020-04-21 20:00 2854

Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder

* First anti-FcRn PoC study for the treatment of NMOSD * Anti-FcRn antibody with potential to become a portfolio-in-a-product CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM) today announced first patient dosing in a Phase1b/2a st...

2020-04-21 17:00 3209

Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex(TM) Aortic Valve Technology

REHOVOT, Israel, April 21, 2020 /PRNewswire/ -- Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a$27 million round of financing, led by Sofinnova Partners, a leading European life scie...

2020-04-21 09:00 2363

Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001

SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou) Co., Lim...

2020-04-20 23:00 1107

Vela Diagnostics receives BARDA funding to develop COVID-19 tests

FAIRFIELD, N.J., April 20, 2020 /PRNewswire/ -- Vela Diagnostics has been awarded a$225,000 contract by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Service...

2020-04-20 21:00 1389

Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries

SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for a significant portion of globally performed ...

2020-04-20 20:00 1795

Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries

SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for a significant portion of globally performed ...

2020-04-20 20:00 3124

IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians

WESTBROOK, Maine, April 20, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test for pets. IDEXX is launching the test in response to customer demand ...

2020-04-20 19:30 4695

Clarivate Enhances Cortellis Clinical Trials Intelligence with New Site Selection Analytics

Clinical trial planning platform enables researchers to pinpoint best sites to support trial protocols and patient recruitment needs LONDON and PHILADELPHIA, April 20, 2020 /PRNewswire/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerat...

2020-04-20 17:07 4848

EDAN to Dispatch Thousands of Medical Devices to NHS Nightingale

SHENZHEN, China, April 20, 2020 /PRNewswire/ -- To ease the strain on medical equipment, EDAN cooperates with the National Health Service (NHS) to install thousands of patient monitors in hospitals in theUnited Kingdom, including Britain's first coronavirus field hospital NHS Nightingale. Other t...

2020-04-20 16:12 1448

Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic

SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today thatthe United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) applic...

2020-04-20 14:41 3217
1 ... 573574575576577578579 ... 608